{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:51:26Z","timestamp":1793904686047,"version":"4.8.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:00:00Z","timestamp":1769299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-31833-1","type":"journal-article","created":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T10:13:14Z","timestamp":1769335994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effects of immersive virtual reality and adaptive cognitive training on cognition and function in parkinson\u2019s disease mild cognitive impairment: a randomized clinical trial"],"prefix":"10.1038","volume":"16","author":[{"given":"Arnau","family":"Puig-Davi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Moreu-Valls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Aracil-Bola\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Fernandez-Coca\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Rodr\u00edguez-Antig\u00fcedad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Kulisevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Horta-Barba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Pagonabarraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Kulisevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul","family":"Martinez-Horta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,25]]},"reference":[{"key":"31833_CR1","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/mds.23661","volume":"26","author":"C Vossius","year":"2011","unstructured":"Vossius, C., Larsen, J. P., Janvin, C. & Aarsland, D. The economic impact of cognitive impairment in parkinson\u2019s disease. Mov. Disord. 26, 1541\u20131544 (2011).","journal-title":"Mov. Disord"},{"key":"31833_CR2","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1002\/mds.29995","volume":"39","author":"A Wijers","year":"2024","unstructured":"Wijers, A., Ravi, A., Evers, S. M. A. A., Tissingh, G. & van Mastrigt, G. A. P. G. Systematic review of the cost of illness of parkinson\u2019s disease from a societal perspective. Mov. Disord. 39, 1938\u20131951 (2024).","journal-title":"Mov. Disord."},{"key":"31833_CR3","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/ana.27035","volume":"96","author":"A Puig-Davi","year":"2024","unstructured":"Puig-Davi, A. et al. Prediction of cognitive heterogeneity in parkinson\u2019s disease: A 4-Year longitudinal study using Clinical, Neuroimaging, biological and electrophysiological biomarkers. Ann. Neurol. 96, 981\u2013993 (2024).","journal-title":"Ann. Neurol."},{"key":"31833_CR4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1001\/jamaneurol.2013.2110","volume":"70","author":"KF Pedersen","year":"2013","unstructured":"Pedersen, K. F., Larsen, J. P., Tysnes, O. B. & Alves, G. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. JAMA Neurol. 70, 580\u2013586 (2013).","journal-title":"JAMA Neurol."},{"key":"31833_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/jnnp-2014-307659","volume":"86","author":"HF Wang","year":"2015","unstructured":"Wang, H. F. et al. Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in parkinson\u2019s disease, parkinson\u2019s disease dementia, and dementia with lewy bodies: systematic review with meta-analysis and trial sequential analysis. J. Neurol. Neurosurg. Psychiatry. 86, 135\u2013143 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"31833_CR6","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1038\/s41598-021-84243-4","volume":"11","author":"K Baik","year":"2021","unstructured":"Baik, K. et al. Donepezil for mild cognitive impairment in parkinson\u2019s disease. Sci. Rep. 11, 4734 (2021).","journal-title":"Sci. Rep."},{"key":"31833_CR7","doi-asserted-by":"publisher","first-page":"175628642513369","DOI":"10.1177\/17562864251336903","volume":"18","author":"J Rodr\u00edguez-Antig\u00fcedad","year":"2025","unstructured":"Rodr\u00edguez-Antig\u00fcedad, J., Olmedo-Saura, G., Pagonabarraga, J., Mart\u00ednez-Horta, S. & Kulisevsky, J. Approaches for treating neuropsychiatric symptoms in parkinson\u2019s disease: a narrative review. Ther. Adv. Neurol. Disord. 18, 17562864251336903 (2025).","journal-title":"Ther. Adv. Neurol. Disord"},{"key":"31833_CR8","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1212\/WNL.0000000000001043","volume":"83","author":"J Pe\u00f1a","year":"2014","unstructured":"Pe\u00f1a, J. et al. Improving functional disability and cognition in Parkinson disease. Neurology 83, 2167\u20132174 (2014).","journal-title":"Neurology"},{"key":"31833_CR9","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/ene.12621","volume":"22","author":"A Petrelli","year":"2015","unstructured":"Petrelli, A. et al. Cognitive training in parkinson\u2019s disease reduces cognitive decline in the long term. Eur. J. Neurol. 22, 640\u2013647 (2015).","journal-title":"Eur. J. Neurol."},{"key":"31833_CR10","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1007\/s00415-021-10568-9","volume":"268","author":"N Schmidt","year":"2021","unstructured":"Schmidt, N. et al. Memory enhancement by multidomain group cognitive training in patients with parkinson\u2019s disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial. J. Neurol. 268, 4655\u20134666 (2021).","journal-title":"J. Neurol."},{"key":"31833_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.parkreldis.2022.02.018","volume":"96","author":"TD van Balkom","year":"2022","unstructured":"van Balkom, T. D. et al. Effect of eight-week online cognitive training in parkinson\u2019s disease: A double-blind, randomized, controlled trial. Parkinsonism Relat. Disord. 96, 80\u201387 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"key":"31833_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/ene.13472","volume":"25","author":"M D\u00edez-Cirarda","year":"2018","unstructured":"D\u00edez-Cirarda, M. et al. Long-term effects of cognitive rehabilitation on brain, functional outcome and cognition in parkinson\u2019s disease. Eur. J. Neurol. 25, 5\u201312 (2018).","journal-title":"Eur. J. Neurol."},{"key":"31833_CR13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.2174\/1871527322666230616121213","volume":"23","author":"S Paola Caminiti","year":"2024","unstructured":"Paola Caminiti, S. et al. Lifestyle modulators of neuroplasticity in parkinson\u2019s disease: evidence in human neuroimaging studies. CNS Neurol. Disord Drug Targets. 23, 602\u2013613 (2024).","journal-title":"CNS Neurol. Disord Drug Targets"},{"key":"31833_CR14","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1007\/s13311-021-01103-9","volume":"18","author":"C Vriend","year":"2021","unstructured":"Vriend, C., van Balkom, T. D., Berendse, H. W., van der Werf, Y. D. & van den Heuvel, O. A. Cognitive training in parkinson\u2019s disease induces Local, not Global, changes in white matter microstructure. Neurotherapeutics 18, 2518\u20132528 (2021).","journal-title":"Neurotherapeutics"},{"key":"31833_CR15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/arclin\/acx092","volume":"32","author":"R Biundo","year":"2017","unstructured":"Biundo, R., Weis, L., Fiorenzato, E. & Antonini, A. Cognitive rehabilitation in parkinson\u2019s disease: is it feasible? Arch. Clin. Neuropsychol. 32, 840\u2013860 (2017).","journal-title":"Arch. Clin. Neuropsychol."},{"key":"31833_CR16","doi-asserted-by":"crossref","unstructured":"D\u00edez-Cirarda, M., Ibarretxe-Bilbao, N., Pe\u00f1a, J. & Ojeda, N. Neurorehabilitation in Parkinson\u2019s Disease: A Critical Review of Cognitive Rehabilitation Effects on Cognition and Brain. Neural Plast 2651918 (2018).","DOI":"10.1155\/2018\/2651918"},{"key":"31833_CR17","doi-asserted-by":"publisher","first-page":"100204","DOI":"10.1016\/j.prdoa.2023.100204","volume":"9","author":"TD van Balkom","year":"2023","unstructured":"van Balkom, T. D. et al. Long-term effects of cognitive training in parkinson\u2019s disease: A randomized, controlled trial. Clin. Parkinsonism Relat. Disorders. 9, 100204 (2023).","journal-title":"Clin. Parkinsonism Relat. Disorders"},{"key":"31833_CR18","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/dneu.20514","volume":"67","author":"BH Dobkin","year":"2007","unstructured":"Dobkin, B. H. Curiosity and cure: translational research strategies for neural Repair-Mediated rehabilitation. Dev. Neurobiol. 67, 1133\u20131147 (2007).","journal-title":"Dev. Neurobiol."},{"key":"31833_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev.neuro.30.051606.094222","volume":"30","author":"VA Alvarez","year":"2007","unstructured":"Alvarez, V. A. & Sabatini, B. L. Anatomical and physiological plasticity of dendritic spines. Annu. Rev. Neurosci. 30, 79\u201397 (2007).","journal-title":"Annu. Rev. Neurosci."},{"key":"31833_CR20","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1080\/09602011.2011.573255","volume":"21","author":"G Berlucchi","year":"2011","unstructured":"Berlucchi, G. Brain plasticity and cognitive neurorehabilitation. Neuropsychological Rehabilitation. 21, 560\u2013578 (2011).","journal-title":"Neuropsychological Rehabilitation"},{"key":"31833_CR21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/cercor\/bht234","volume":"25","author":"SB Chapman","year":"2015","unstructured":"Chapman, S. B. et al. Neural mechanisms of brain plasticity with complex cognitive training in healthy seniors. Cereb. Cortex. 25, 396\u2013405 (2015).","journal-title":"Cereb. Cortex"},{"key":"31833_CR22","doi-asserted-by":"publisher","first-page":"102146","DOI":"10.1016\/j.arr.2023.102146","volume":"93","author":"C Tortora","year":"2024","unstructured":"Tortora, C. et al. Virtual reality and cognitive rehabilitation for older adults with mild cognitive impairment: A systematic review. Ageing Res. Rev. 93, 102146 (2024).","journal-title":"Ageing Res. Rev."},{"key":"31833_CR23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s00415-025-12927-2","volume":"272","author":"A Moreu-Valls","year":"2025","unstructured":"Moreu-Valls, A. et al. A randomized clinical trial to evaluate the efficacy of cognitive rehabilitation and music therapy in mild cognitive impairment in huntington\u2019s disease. J. Neurol. 272, 202 (2025).","journal-title":"J. Neurol."},{"key":"31833_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/jpm11050429","volume":"11","author":"I Sanchez-Luengos","year":"2021","unstructured":"Sanchez-Luengos, I. et al. Effectiveness of cognitive rehabilitation in parkinson\u2019s disease: A systematic review and Meta-Analysis. J. Pers. Med. 11, 429 (2021).","journal-title":"J. Pers. Med."},{"key":"31833_CR25","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s10072-021-05772-4","volume":"43","author":"A Giustiniani","year":"2022","unstructured":"Giustiniani, A., Maistrello, L., Danesin, L., Rigon, E. & Burgio, F. Effects of cognitive rehabilitation in Parkinson disease: a meta-analysis. Neurol. Sci. 43, 2323\u20132337 (2022).","journal-title":"Neurol. Sci."},{"key":"31833_CR26","first-page":"818","volume":"58","author":"N Marotta","year":"2022","unstructured":"MAROTTA, N. et al. Integrating virtual reality and exergaming in cognitive rehabilitation of patients with Parkinson disease: a systematic review of randomized controlled trials. Eur. J. Phys. Rehabil Med. 58, 818\u2013826 (2022).","journal-title":"Eur. J. Phys. Rehabil Med."},{"key":"31833_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/02692155231213476","volume":"38","author":"Y Ren","year":"2024","unstructured":"Ren, Y., Wang, Q., Liu, H., Wang, G. & Lu, A. Effects of immersive and non-immersive virtual reality-based rehabilitation training on cognition, motor function, and daily functioning in patients with mild cognitive impairment or dementia: A systematic review and meta-analysis. Clin. Rehabil. 38, 305\u2013321 (2024).","journal-title":"Clin. Rehabil"},{"key":"31833_CR28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/bios15020102","volume":"15","author":"J Song","year":"2025","unstructured":"Song, J. et al. Development of neurodegenerative disease diagnosis and monitoring from traditional to digital biomarkers. Biosensors 15, 102 (2025).","journal-title":"Biosensors"},{"key":"31833_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-024-01217-2","volume":"7","author":"Y Sun","year":"2024","unstructured":"Sun, Y., Wang, Z., Liang, Y., Hao, C. & Shi, C. Digital biomarkers for precision diagnosis and monitoring in parkinson\u2019s disease. Npj Digit. Med. 7, 1\u201310 (2024).","journal-title":"Npj Digit. Med."},{"key":"31833_CR30","doi-asserted-by":"publisher","first-page":"e12785","DOI":"10.2196\/12785","volume":"21","author":"A Piau","year":"2019","unstructured":"Piau, A., Wild, K., Mattek, N. & Kaye, J. Current state of digital biomarker technologies for Real-Life, Home-Based monitoring of cognitive function for mild cognitive impairment to mild alzheimer disease and implications for clinical care: systematic review. J. Med. Internet Res. 21, e12785 (2019).","journal-title":"J. Med. Internet Res."},{"key":"31833_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1001\/jamaneurol.2024.3533","volume":"82","author":"CM Erickson","year":"2025","unstructured":"Erickson, C. M., Wexler, A. & Largent, E. A. Digital biomarkers for neurodegenerative disease. JAMA Neurol. 82, 5\u20136 (2025).","journal-title":"JAMA Neurol."},{"key":"31833_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13195-020-00612-7","volume":"12","author":"PNE Young","year":"2020","unstructured":"Young, P. N. E. et al. Imaging biomarkers in neurodegeneration: current and future practices. Alzheimer\u2019s Res. Therapy. 12, 49 (2020).","journal-title":"Alzheimer\u2019s Res. Therapy"},{"key":"31833_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41582-022-00753-3","volume":"19","author":"M Perovnik","year":"2023","unstructured":"Perovnik, M., Rus, T., Schindlbeck, K. A. & Eidelberg, D. Functional brain networks in the evaluation of patients with neurodegenerative disorders. Nat. Rev. Neurol. 19, 73\u201390 (2023).","journal-title":"Nat. Rev. Neurol."},{"key":"31833_CR34","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1002\/hbm.24593","volume":"40","author":"I Aracil-Bola\u00f1os","year":"2019","unstructured":"Aracil-Bola\u00f1os, I. et al. A divergent breakdown of neurocognitive networks in parkinson\u2019s disease mild cognitive impairment. Hum. Brain Mapp. 40, 3233\u20133242 (2019).","journal-title":"Hum. Brain Mapp."},{"key":"31833_CR35","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston, G. et al. Dementia prevention, intervention, and care: 2024 report of the lancet standing commission. Lancet 404, 572\u2013628 (2024).","journal-title":"Lancet"},{"key":"31833_CR36","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement disorder Society-sponsored revision of the unified parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170 (2008).","journal-title":"Mov. Disord."},{"key":"31833_CR37","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","volume":"11","author":"L Klingelhoefer","year":"2015","unstructured":"Klingelhoefer, L. & Reichmann, H. Pathogenesis of Parkinson disease\u2013the gut-brain axis and environmental factors. Nat. Rev. Neurol. 11, 625\u2013636 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"31833_CR38","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.parkreldis.2013.05.007","volume":"19","author":"J Kulisevsky","year":"2013","unstructured":"Kulisevsky, J. et al. Measuring functional impact of cognitive impairment: validation of the parkinson\u2019s disease cognitive functional rating scale. Parkinsonism Relat. Disord. 19, 812\u2013817 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"31833_CR39","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson, C. L. et al. Systematic review of Levodopa dose equivalency reporting in parkinson\u2019s disease. Mov. Disord. 25, 2649\u20132653 (2010).","journal-title":"Mov. Disord."},{"key":"31833_CR40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan, I. et al. Diagnostic criteria for mild cognitive impairment in parkinson\u2019s disease: movement disorder society task force guidelines. Mov. Disord. 27, 349\u2013356 (2012).","journal-title":"Mov. Disord"},{"key":"31833_CR41","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/mds.25568","volume":"28","author":"R de Fern\u00e1ndez","year":"2013","unstructured":"de Fern\u00e1ndez, R. et al. Parkinson\u2019s disease-cognitive rating scale: psychometrics for mild cognitive impairment. Mov. Disord. 28, 1376\u20131383 (2013).","journal-title":"Mov. Disord."},{"key":"31833_CR42","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/mds.22007","volume":"23","author":"J Pagonabarraga","year":"2008","unstructured":"Pagonabarraga, J. et al. Parkinson\u2019s disease-cognitive rating scale: A new cognitive scale specific for parkinson\u2019s disease. Mov. Disord. 23, 998\u20131005 (2008).","journal-title":"Mov. Disord."},{"key":"31833_CR43","doi-asserted-by":"publisher","first-page":"10S","DOI":"10.1212\/WNL.48.5_Suppl_6.10S","volume":"48","author":"JL Cummings","year":"1997","unstructured":"Cummings, J. L. The neuropsychiatric inventory. Neurology 48, 10S\u201316S (1997).","journal-title":"Neurology"},{"key":"31833_CR44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1176\/jnp.4.2.134","volume":"4","author":"Reliability","year":"1992","unstructured":"Reliability validity, and clinical correlates of apathy in parkinson\u2019s disease. JNP 4, 134\u2013139 (1992).","journal-title":"JNP"},{"key":"31833_CR45","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.neuroimage.2015.02.064","volume":"112","author":"RHR Pruim","year":"2015","unstructured":"Pruim, R. H. R. et al. ICA-AROMA: A robust ICA-based strategy for removing motion artifacts from fMRI data. NeuroImage 112, 267\u2013277 (2015).","journal-title":"NeuroImage"},{"key":"31833_CR46","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1093\/cercor\/bhx179","volume":"28","author":"A Schaefer","year":"2018","unstructured":"Schaefer, A. et al. Local-Global parcellation of the human cerebral cortex from intrinsic functional connectivity MRI. Cereb. Cortex. 28, 3095\u20133114 (2018).","journal-title":"Cereb. Cortex"},{"key":"31833_CR47","unstructured":"Nilearn Contributors. Nilearn. Zenodo. (2025)."},{"key":"31833_CR48","doi-asserted-by":"publisher","first-page":"104736","DOI":"10.1016\/j.neubiorev.2022.104736","volume":"139","author":"I Molnar-Szakacs","year":"2022","unstructured":"Molnar-Szakacs, I. & Uddin, L. Q. Anterior Insula as a gatekeeper of executive control. Neurosci. Biobehavioral Reviews. 139, 104736 (2022).","journal-title":"Neurosci. Biobehavioral Reviews"},{"key":"31833_CR49","doi-asserted-by":"publisher","first-page":"101671","DOI":"10.1016\/j.arr.2022.101671","volume":"80","author":"HM Gavelin","year":"2022","unstructured":"Gavelin, H. M. et al. Computerized cognitive training in parkinson\u2019s disease: A systematic review and meta-analysis. Ageing Res. Rev. 80, 101671 (2022).","journal-title":"Ageing Res. Rev."},{"key":"31833_CR50","doi-asserted-by":"publisher","first-page":"e35224","DOI":"10.2196\/35224","volume":"5","author":"KY Ho","year":"2022","unstructured":"Ho, K. Y. et al. Virtual reality intervention for managing apathy in people with cognitive impairment: systematic review. JMIR Aging. 5, e35224 (2022).","journal-title":"JMIR Aging"},{"key":"31833_CR51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/bioengineering11010035","volume":"11","author":"V Catania","year":"2024","unstructured":"Catania, V., Rundo, F., Panerai, S. & Ferri, R. Virtual reality for the rehabilitation of acquired cognitive disorders: A narrative review. Bioengineering 11, 35 (2024).","journal-title":"Bioengineering"},{"key":"31833_CR52","doi-asserted-by":"publisher","first-page":"123507","DOI":"10.1016\/j.jns.2025.123507","volume":"473","author":"E Fiorenzato","year":"2025","unstructured":"Fiorenzato, E. et al. Effects of virtual reality cognitive training on executive function and prospective memory in parkinson\u2019s disease and healthy aging. J. Neurol. Sci. 473, 123507 (2025).","journal-title":"J. Neurol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31833-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31833-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31833-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:03:26Z","timestamp":1769511806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31833-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,25]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31833"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31833-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,25]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The present study has been approved by the Hospital de la Santa Creu i Sant Pau ethics committee (IIBSP-MOV-2021-28) and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments (ClinicalTrials.gov number, NCT05769972).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations"}}],"article-number":"3499"}}